Baker Avenue Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Buy |
+2,716
| New | +$212K | 0.01% | 458 |
|
|
2025
Q1 | – | Sell |
-3,369
| Closed | -$249K | – | 460 |
|
|
2024
Q4 | $249K | Buy |
+3,369
| New | +$249K | 0.01% | 370 |
|
|
2023
Q4 | – | Sell |
-713
| Closed | -$49.4K | – | 700 |
|
|
2023
Q3 | $49.4K | Sell |
713
-22
| -3% | -$1.52K | ﹤0.01% | 519 |
|
|
2023
Q2 | $69.3K | Sell |
735
-102
| -12% | -$9.62K | ﹤0.01% | 476 |
|
|
2023
Q1 | $69.2K | Buy |
837
+145
| +21% | +$12K | ﹤0.01% | 483 |
|
|
2022
Q4 | $51.6K | Buy |
+692
| New | +$51.6K | ﹤0.01% | 487 |
|
|
2022
Q2 | – | Sell |
-25,940
| Closed | -$3.05M | – | 308 |
|
|
2022
Q1 | $3.05M | Buy |
25,940
+2,513
| +11% | +$296K | 0.16% | 104 |
|
|
2021
Q4 | $3.04M | Buy |
+23,427
| New | +$3.04M | 0.15% | 106 |
|